Influence of psychological factors on risk of temporomandibular disorders

Journal of Dental Research

Volumn 86, Issue 11, 2007, Pages 1120-1125

  Slade, G D ^a   Diatchenko, L ^b   Bhalang, K ^c   Sigurdsson, A ^b   Fillingim, R B ^d   Belfer, I ^e   Max, M B ^e   Goldman, D ^f   Maixner, W ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c CHULALONGKORN UNIVERSITY   (Thailand)

^d UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^e NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^f NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Catechol O methyltransferase; Cohort studies; Genetics; Psychology; Temporomandibular joint disorders

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; DEPRESSION; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MENTAL STRESS; MOOD DISORDER; PAIN ASSESSMENT; PAIN THRESHOLD; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPOROMANDIBULAR JOINT DISORDER;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; MOOD DISORDERS; PAIN MEASUREMENT; PAIN THRESHOLD; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK FACTORS; STRESS, PSYCHOLOGICAL; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 36549050936     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910708601119     Document Type: Article

References (25)

1. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, et al. (2003). A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73:152-161.
2. Cohen S, Kamarck T, Mermelstein R (1983). A global measure of perceived stress. J Health Social Behavior 24:385-396.
3. Dao TT, Lavigne GJ, Charbonneau A, Feine JS, Lund JP (1994). The efficacy of oral splints in the treatment of myofascial pain of the jaw muscles: a controlled clinical trial. Pain 56:85-94.
4. Derogatis LR, Melisaratos N (1983). The Brief Symptom Inventory: an introductory report. Psychol Med 13:595-605.
5. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, et al. (2005). Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14:135-143.
6. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, et al. (2006). Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 125:216-224.
7. Drangsholt M, LeResche L (1999). Temporomandibular disorder pain. In: Epidemiology of pain. Crombie IK, Croft PR, Linton SJ, LeResche L, Von Korff M, editors. Seattle: IASP Press.
8. Dworkin SF, LeResche L (1992). Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 6:301-355.
9. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
10. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D (2003). Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 13:33-41.
11. Fagius AN, Wahren LK (1981). Variability of sensory threshold determination in clinical use. J Neurol Sci 51:11-27.
12. Fruhstorfer H, Lindblom U, Schmidt WG (1976). Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatry 39:1071-1075.
13. Glatt SJ, Faraone SV, Tsuang MT (2003). Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 160:469-476.
14. Gracely RH (1999). Studies of pain in human subjects. In: Textbook of pain. 4th ed. Wall PD, Melzack R, editors. London, UK: Churchill Livingstone, pp. 385-408.
15. Jaeger B, Reeves JL (1986). Quantification of changes in myofascial trigger point sensitivity with the pressure algometer following passive stretch. Pain 27:203-210.
16. Lorr M, McNair DM (1988). Profile of mood states: bipolar form. San Diego: Educational and Industrial Testing Service.
17. Maixner W, Gracely RH, Zuniga JR, Humphrey CB, Bloodworth GR (1990). Cardiovascular and sensory responses to forearm ischemia and dynamic hand exercise. Am J Physiol 259:R1156-R1163.
18. Maixner W, Fillingim R, Sigurdsson A, Kincaid S, Silva S (1998). Sensitivity of patients with painful temporomandibular disorders to experimentally evoked pain: evidence for altered temporal summation of pain. Pain 76:71-81.
19. Okeson JP (1996). Differential diagnosis and management considerations of temporomandibular disorders. In: Orofacial pain. Okeson JP, editor. Chicago: Quintessence, pp. 113-184.
20. Price DD, Hu JW, Dubner R, Gracely RH (1977). Peripheral suppression of first pain and central summation of second pain evoked by noxious heat pulses. Pain 3:57-68.
21. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Weizman A (2002). A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296-1302.
22. Spielberger CD, Gorusch RL, Lushene R, Vagg PR, Jacobs GA (1983). Manual for the State-Trait Anxiety Inventory (Form Y1). Palo Alto, CA: Consulting Psychologists Press.
23. Svensson P, Graven-Nielsen T (2001). Craniofacial muscle pain: review of mechanisms and clinical manifestations. J Orofac Pain 15:117-145.
24. Von Korff M, LeResche L, Dworkin SF (1993). First onset of common pain symptoms: a prospective study of depression as a risk factor. Pain 55:251-258.
25. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, et al. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240-1243.